Navigation Links
Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting

LOS ANGELES--(BUSINESS WIRE)--May 21, 2007 - Cougar Biotechnology, Inc. (OTCBB:CGRB) today announced that positive Phase I and Phase II data on the Company's prostate cancer drug candidate CB7630 (abiraterone acetate) was presented at the American Urological Association (AUA) Annual Meeting, which is currently taking place in Anaheim, California. The data was presented by Dr. Timothy A. Yap from the Cancer Research UK Centre for Cancer Therapeutics at The Institute of Cancer Research in an oral presentation entitled, "Abiraterone acetate, an inhibitor of androgen synthesis, has significant antitumor activity in castration resistant prostate cancer."

The Phase I/II trial of CB7630 was conducted at The Institute of Cancer Research and at The Royal Marsden NHS Foundation Trust in the United Kingdom. In the trial, CB7630 was administered orally, once daily, to chemotherapy-naive patients with castration refractory prostate cancer (CRPC), who had progressive disease despite treatment with LHRH analogues and multiple other hormonal therapies, including antiandrogens, diethylstilboestrol and dexamethasone. To date a total of 38 patients have been treated in the Phase I/II trial, including 15 patients treated in the Phase I portion of the trial and 23 patients treated in the Phase II portion of the trial. In his presentation, Dr. Yap reported that in the 38 patients treated in this trial, CB7630 was well tolerated at doses as high as 2000 mg/day with minimal toxicity. Moreover, no dose limiting toxicity has been observed in the trial to date.

In the 30 patients who were evaluable in the Phase I/II trial, 18 patients (60%) experienced a confirmed decline in prostate specific antigen (PSA) levels of greater than 50%, with 10 of the 30 patients (33%) experiencing PSA declines of greater than 90%. Six additional patients (20%) experienced a decline in PSA that was less than 50%. Of the 20 evaluable patients with mea
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
3. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
7. Prana Biotechnology Presents New Key Findings on PBT2
8. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:7/14/2014)... July 14, 2014  More than any other generation, Millennials ... tablet computers -- but their eyes don,t. These mobile devices ... before, and the eye has not evolved to cope with ... eyes can do comfortably often results in tired eyes, focusing ... Digital Eye Strain. Now ZEISS has invented a new type ...
(Date:7/14/2014)... , July 14, 2014  Diomics, Inc., ... today announced that the United States Patent and ... by Diomics covering novel biologic sample collection materials, ... use in forensics and diagnostics. ... is by swabbing. Recovery of DNA from a ...
(Date:7/14/2014)... Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... that it will hold its 2014 Annual Meeting of Shareholders on Wednesday, ... held at No. 39 Shangdi Xi Road, Haidian District, Beijing ... will be eligible to vote and are invited to attend. ... Weidong Yin , Yuk Lam Lo , Simon Anderson ...
Breaking Medicine Technology:New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2Sinovac Schedules 2014 Annual Meeting of Shareholders 2Sinovac Schedules 2014 Annual Meeting of Shareholders 3
(Date:7/14/2014)... 14, 2014 The inability to ignore irrelevant stimuli ... by individuals diagnosed with schizophrenia, reports a new study ... , Our brains are usually good at focusing on ... filtering out the "noise" or thoughts that aren,t relevant. ... part to a problem with this filtering process, which ...
(Date:7/14/2014)... 2014)In the 2,500+ years that have passed since ... it has been used to treat a number ... and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, ... a few. Now, a meta-analysis of randomized ... in Menopause , the journal of The ...
(Date:7/14/2014)... 2014 According to a recent ... have discovered a connection between women with high levels ... infertility. Although doctors have theorized about the role stress ... study to provide scientific support. , “Stress, if very ... Dr. Larry Barmat, an OB/GYN who specializes in reproductive ...
(Date:7/14/2014)... Philadelphia, PA (PRWEB) July 14, 2014 ... and software solutions to healthcare problems have been ... ’s first Digital Health Accelerator (DHA). , ... 69 applicants via a multi-stage process. They include ... and two overseas companies—Keosys (from France) and Pulse ...
(Date:7/14/2014)... Royal Academy, senescent is he who "begins to age". ... only is senescence not a synonym of ageing, it ... senescence is such a badly named physiological process that ... needs another name. That is the case of Manuel ... one of the world,s leading experts on senescence, who ...
Breaking Medicine News(10 mins):Health News:'Noisy' memory in schizophrenia 2Health News:Bothered by hot flashes? Acupuncture might be the answer 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3
... have identified two genes believed to play a role in ... to better diagnosis and treatment of this increasingly common form ... or womb cancer, is the most common malignant cancer of ... of cases being detected has increased markedly, as has mortality. ...
... While studying an HIV protein that plays an essential ... Pittsburgh School of Medicine have discovered compounds that show ... drug discovery efforts have met with little success in ... factor, called Nef, because it lacks biochemical activity that ...
... how your eyes adjust during a blackout? When we go ... must quickly adjust. Vision scientists at Washington University School of ... allows the human eye to adapt to darkness very quickly. ... bright light. The discovery could contribute to better understanding ...
... treatments instead, study finds, , TUESDAY, Oct. 13 (HealthDay News) ... cancer are not turning to mastectomy as their first choice ... as lumpectomy, a new survey has found. , The survey, ... of the American Medical Association , also found that U.S. ...
... ... Support for the Nationwide Health Information Network. , ... Chantilly, VA (PRWEB) October 13, 2009 -- Agilex Technologies, Inc. , ... and public sectors , today announced the appointment of Melissa Chapman to the ...
... fastest-growing retailer of authentic nonfat frozen yogurt, announced it ... , to celebrate the favorite food of the fall ... Spice frozen yogurt, available at all Red Mango ... 13, through December 31, 2009. , (Photo: ...
Cached Medicine News:Health News:Genes behind increasingly common form of cancer identified 2Health News:Pitt researchers find candidates for new HIV drugs 2Health News:Researchers discover mechanism that helps humans see in bright and low light 2Health News:Researchers discover mechanism that helps humans see in bright and low light 3Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 2Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 3Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 2Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 3Health News:Discover Red Mango's New Seasonal Flavor: Pumpkin Spice 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: